Home Newsfeeds European Google Rivals Want EU Tech Law Used in Antitrust Case

European Google Rivals Want EU Tech Law Used in Antitrust Case

-Reuters https://www.reuters.com/technology/exclusive-scores-google-rivals-want-eu-tech-law-used-antitrust-case-letter-2022-10-17/

byCharles Gross

October 17, 2022

1 minute read

-Reuters

https://www.reuters.com/technology/exclusive-scores-google-rivals-want-eu-tech-law-used-antitrust-case-letter-2022-10-17/

UMC Co-President Wang Optimistic Despite Q4 Challenges, Expects Mild Wafer Demand Increase

By Anusuya Lahiri

January 31, 12:53 PM

UMC reports $1.79B revenue in Q4 FY23, beating consensus of $1.70B. Co-president expects overall wafer demand will increase mildly.

UMC

MediciNova Announces New Data And Results Of A Phase 2 Clinical Trial Of MN-166 In Glioblastoma Presented At The 28th Annual Meeting Of The Society For Neuro-Oncology

By Benzinga Newsdesk

November 19, 11:03 PM

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova's collaborator,

MNOV

Bitcoin, Ethereum, Dogecoin Slide: Analyst Warns Of ‘Very Volatile’ Week Ahead

By Shivdeep Dhaliwal

October 2, 9:20 PM

Major coins showed weakness Sunday evening as the global cryptocurrency market cap shrunk 1.4% to $922.5 billion at 8:05 p.m. EDT.

$DOGE

Lineage Cell Therapeutics Announces OpRegen Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit

By Benzinga Newsdesk

May 6, 8:04 AM

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients (n=10)BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion (n=5)Maintenance or increases in external

LCTX

European Google Rivals Want EU Tech Law Used in Antitrust Case

Related Posts

UMC Co-President Wang Optimistic Despite Q4 Challenges, Expects Mild Wafer Demand Increase

MediciNova Announces New Data And Results Of A Phase 2 Clinical Trial Of MN-166 In Glioblastoma Presented At The 28th Annual Meeting Of The Society For Neuro-Oncology

Bitcoin, Ethereum, Dogecoin Slide: Analyst Warns Of ‘Very Volatile’ Week Ahead

Lineage Cell Therapeutics Announces OpRegen Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit